EU regulator could issue decision on Pfizer COVID-19 pill 'within weeks'

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Qulity Score:
  • News: 8%
  • Publisher: 66%

The European Union\u0027s drug regulator said on Monday (Jan 10) it could issue \u0022within weeks\u0022 a decision on whether to approve the use of Pfizer\u0027s COVID-19 pill, Paxlovid, after the US drugmaker submitted an application seeking authorisation. The approval sought is for the treatment of mild-to-moderate CO

Singapore Headlines News

Singapore Latest News, Singapore Headlines

The European Union's drug regulator said on Monday it could issue"within weeks" a decision on whether to approve the use of Pfizer's COVID-19 pill, Paxlovid, after the US drugmaker submitted an application seeking authorisation.

While vaccines are central to the fight against the pandemic, regulators are looking at therapies as a new tool against the fast-spreading Omicron variant, which has now been detected in more than 128 countries around the world.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

How soon singapore can get?

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Over $141k in fines issued for breach of Covid-19 workplace safety rules in 2021
Source: straits_times - 🏆 5. / 69 Read more »

T-cells from common colds can provide protection against COVID-19 - studyLONDON : High levels of T-cells from common cold coronaviruses can provide protection against COVID-19, an Imperial College London study published on Monday has found, which could inform approaches for second-generation vaccines.Immunity against COVID-19 is a complex picture, and while there is evidence o Hahaha! Yes, some of us knew this a very long time ago. But you go right ahead with 2,3 or 4 jabs! Well Covid is a coronavirus, as is the common cold, so this makes perfect sense. Also means we will probably never find a cure unfortunately.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Indonesia approves five COVID-19 vaccines for booster shotsJAKARTA: Indonesian authorities on Monday (Jan 10) granted emergency authorisation for the use of five different COVID-19 vaccines as booster shots that will prioritise vulnerable groups. Penny Lukito, head of Indonesia’s Food and Drug Monitoring Agency, said Sinovac, Pfizer, AstraZeneca, Moderna and Zif
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Nepal closes schools as COVID-19 cases spikeKATHMANDU: Schools across Nepal will close for nearly three weeks after a spike in coronavirus cases, a government spokesman said on Monday (Jan 10), forcing more than seven million students to stay at home. Nepal reported 841 new cases on Sunday, the biggest single-day jump since September last year, taki poor girls
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Pope on COVID-19 vaccines says healthcare a 'moral obligation'ROME: Pope Francis suggested on Monday (Jan 10) that getting vaccinated against the coronavirus was a “moral obligation\u0022 and denounced how people had been swayed by “baseless information” to refuse one of the most effective measures to save lives. Francis used some of his strongest words yet cal
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

T-cells from common colds can provide protection against Covid-19: StudyLONDON — High levels of T-cells from common cold coronaviruses can provide protection against Covid-19, an Imperial College London study published on Monday (Jan 10) has found, which could inform approaches for second-generation vaccines. Hahaha! Yes, some of us knew this a very long time ago. But you go right ahead with 2,3 or 4 jabs!
Source: TODAYonline - 🏆 1. / 99 Read more »